Pfizer’s COVID-19 antiviral pill will already have some competition in the US: The Food and Drug Administration has given emergency use authorization for Merck’s Molnupiravir pill.
Womp, womp: Efficacy of Merck’s Thor-inspired COVID pill crumbles, vexing experts
FDA advisers voted 13-to-10 in favor of authorization given risks and modest benefits.
Storm brews over 46x price markup of Merck’s Thor-inspired COVID pill
Drug developed with $35M in federal funds; Merck expected to reap billions.